More Globe Newswire

View Older Stories View Newer Stories

Sep 4, 2024 08:00AM Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Sep 4, 2024 08:00AM Cynomi's State of the Virtual CISO Report 2024 Reveals Significant Growth Opportunities for Service Providers
Sep 4, 2024 08:00AM electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Sep 4, 2024 08:00AM 60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Sep 4, 2024 08:00AM Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock
Sep 4, 2024 08:00AM Allyx Therapeutics Announces First Parkinson’s Disease Patient Treated with ALX-001
Sep 4, 2024 08:00AM Enphase Energy Announces Solution for Expanding Legacy NEM Solar Energy Systems in California
Sep 4, 2024 08:00AM Gabelli Funds to Host 30th Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 5, 2024
Sep 4, 2024 08:00AM LifeVantage Welcomes Back AXIO® Lemonade—Now As a Permanent Flavor
Sep 4, 2024 08:00AM Nanocarry Therapeutics' Brain Penetrating Nanoplatform Selected by the NCI Nanotechnology Characterization Laboratory for its Preclinical Characterization Program
Sep 4, 2024 08:00AM Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
Sep 4, 2024 08:00AM Ecocem Appoints Mike Donovan as United States Technical Director to Support Growth Strategy
Sep 4, 2024 08:00AM OncoC4 Announces First Patient Dosed in Phase 1 Trial for Novel SIGLEC10 Immune Checkpoint Inhibitor ONC-841 for Solid Tumors
Sep 4, 2024 08:00AM Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
Sep 4, 2024 08:00AM Holiday Island Holdings, Inc. Has Started Oil Production at Its Windy Point Well in Central Texas
Sep 4, 2024 08:00AM Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations
Sep 4, 2024 08:00AM Catalogic Enhances CloudCasa with Expanded Volume Type Support and Cloud Integration Enhancements
Sep 4, 2024 08:00AM Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients
Sep 4, 2024 08:00AM Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients
Sep 4, 2024 08:00AM CytomX Therapeutics to Present at Upcoming September Investor Conferences
Sep 4, 2024 08:00AM Cloudbeds to usher in the era of 'decision intelligence' at upcoming Passport conference
Sep 4, 2024 08:00AM ODYSIGHT.AI ANNOUNCES PURCHASE ORDER AGREEMENT EXCEEDING $10M FOR ITS PREDICTIVE MAINTENANCE SOLUTION, FROM A LEADING INTERNATIONAL DEFENSE CONTRACTOR, TO BE FULLY INTEGRATED IN ITS NEW UAV CONFIGURAT
Sep 4, 2024 08:00AM GDEV announces unaudited results for the second quarter and first half of 2024
Sep 4, 2024 08:00AM Singing Machine Announces Availability of New Sesame Street Branded Product Line
Sep 4, 2024 08:00AM Worksport Ltd. Unveils New Models, Driving Rapid Product Expansion
Sep 4, 2024 08:00AM GraniteShares new Short and Leveraged Single Stock ETF launches Highlights: 2X Palantir, 2X UBER, and -1X Coinbase
Sep 4, 2024 08:00AM Sacks Parente Golf Announces Strategic Corporate Rebranding
Sep 4, 2024 08:00AM Duos Edge AI Launches First Edge Data Center
Sep 4, 2024 08:00AM ALX Oncology Announces First Patients Dosed with Evorpacept and Sarclisa As Part of Randomized Phase 1/2 UMBRELLA Study with Sanofi
Sep 4, 2024 08:00AM Stronghold Provides August 2024 Bitcoin Mining and Operational Update
Sep 4, 2024 08:00AM Golden Matrix Group Introduces Version 2.0 of Its AI-Powered Casino Game Recommender
Sep 4, 2024 08:00AM ARS Pharmaceuticals Launches Pre-Ordering Services for neffy® to Help Patients Access the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
Sep 4, 2024 08:00AM PharmaTher Announces Update on FDA New Drug Application for Ketamine
Sep 4, 2024 08:00AM PodcastOne (Nasdaq: PODC) and Nic and Ryan Nemeth Tag Team for Joint Venture Nemeth Bros Podcast
Sep 4, 2024 08:00AM Shoals Announces Partnership in the Kingdom of Saudi Arabia
Sep 4, 2024 08:00AM Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
Sep 4, 2024 08:00AM Cross Keys Capital Advises Illinois CancerCare in Its Strategic Relationship with The US Oncology Network
Sep 4, 2024 08:00AM 1win Successfully Launches 1win Token: A New Digital Asset for the Broader Blockchain Ecosystem
Sep 4, 2024 08:00AM Cloudbeds to usher in the era of 'decision intelligence' at upcoming Passport conference
Sep 4, 2024 08:00AM Gabelli Funds to Host 30th Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 5, 2024
Sep 4, 2024 08:00AM Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Sep 4, 2024 08:00AM Constellium-led ALIVE collaborative research project achieves 12 to 35 percent weight savings for EV battery enclosures with optimized designs and manufacturing processes
Sep 4, 2024 08:00AM Advantage Solutions unveils comprehensive rebrand, emphasizing unified market approach
Sep 4, 2024 08:00AM Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
Sep 4, 2024 08:00AM HireVue Announces 2024 Customer Excellence Award Winners
Sep 4, 2024 08:00AM RARE AND SOUGHT-AFTER BOURBONS MAKE THEIR DEBUT AT THE ART OF BOURBON SEPT 12
Sep 4, 2024 08:00AM A New Era in Publisher Monetization: Aditude Acquires Category Leader Hashtag Labs
Sep 4, 2024 08:00AM Collegium Completes Acquisition of Ironshore Therapeutics
Sep 4, 2024 08:00AM Solid Biosciences to Participate at Upcoming Investor Conferences
Sep 4, 2024 08:00AM Ovid Therapeutics to Present at Upcoming September Investor Conferences
View Newer Stories View Older Stories